Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
384
¥100 million (year-on-year increase in revenue; operating profit increased by ¥12.6 billion)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationFirst quarter of the fiscal year ending December 20269 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales5,380 Hundreds of millions of yen
Operating profit385 Hundreds of millions of yen
Net income¥228 100 million net income attributable to owners of the parent
Results for the three months of the current quarter
Net Sales¥538.0 billion
Operating profit¥38.5 billion
Income before taxes¥35.0 billion
Profit attributable to owners of the parent¥22.8 billion
Full-year earnings forecast
Net Sales
22,000 Hundreds of millions of yen
Operating profit
1,500 Hundreds of millions of yen
Income before taxes
1,240 Hundreds of millions of yen
Profit attributable to owners of the parent
770 Hundreds of millions of yen
Dividend per share
¥210
Operating profit margin
6.8 %
ROE
5.2 %
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales24%
Operating profit26%
By segmentArchitectural Glass 23%/23%, Automotive 27%/27%, Electronics 25%/27%, Chemicals 23%/27%, Life Science 22%/66%, Ceramics and Other 18%/38%, Total 24%/26% (revenue/operating profit for each segment)
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Foreign exchange impact+¥28.4 billion
- Impact of changes in the scope of consolidation-¥600 million
- Yen depreciation effectAmount not disclosed
- Higher shipments in Essential Chemicals Southeast AsiaAmount not disclosed
- Effect of pricing measures in European Architectural GlassAmount not disclosed
- Improved profitability in Life ScienceAmount not disclosed
- Lower natural gas prices in EuropeAmount not disclosed
- Increase in business structure improvement costsAmount not disclosed
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
- Average USD/JPY during the period¥155.0/USD
- Average EUR/JPY during the period¥180.0/EUR
- Crude oil (Dubai, average during the period)100.0 USD/BBL
New initiatives
- Repair of architectural glass manufacturing furnaces
- Expansion of electronics manufacturing equipment, including semiconductor-related equipment
- Expansion of biopharmaceutical CDMO capacity
- Diversification of procurement sources, cost reductions, production adjustments and appropriate pricing in response to the situation in the Middle East
Key KPIsA metric the company considers important as a management benchmark.
- D/E ratio0.41 times
- Full-year ROE forecast5.2 %
- Automobile production (Japan)+2 % year on year
- Automobile production (North America)▲3
- Automobile production (Europe)▲3
- Display panel demand (global, area basis)▲1
Unit price and quantity metricsThese figures show sales broken down by price and volume.
For architectural glass, automobile production and display panel demand, the materials provide volume and price or demand area data. Combinations such as customer numbers and average spending per customer are not disclosed.Segment results
- Architectural GlassNet Sales¥112.0 billion (up ¥8.0 billion year on year)Operating profit¥4.7 billion (up ¥5.6 billion)
- AutomotiveNet Sales¥137.6 billion (up ¥8.9 billion)Operating profit¥8.6 billion (up ¥1.0 billion)
- ElectronicsNet Sales¥90.3 billion (up ¥3.6 billion)Operating profit¥12.3 billion (down ¥1.8 billion)
- ChemicalsNet Sales¥157.2 billion (up ¥13.1 billion)Operating profit¥15.2 billion (up ¥4.1 billion)
- Life ScienceNet Sales¥35.6 billion (up ¥4.6 billion)Operating profit-¥3.3 billion (up ¥2.8 billion)
- Ceramics and OtherNet Sales¥11.0 billion (down ¥2.4 billion)Operating profit¥0.8 billion (up ¥0.8 billion)
Financial targets
ROEFY2026 forecast 5.2%
D/E ratio0.37x at December 2025-end, 0.41x at March 2026-end
Equity ratio50% at December 2025-end
Capital expenditures
¥441 100 million FY2026 first quarter) / full-year forecast: ¥190.0 billion
Annual Dividend
Annual¥210 per share
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending December 2026 |
| Net Sales | 5,380 Hundreds of millions of yen |
| Operating profit | 385 Hundreds of millions of yen |
| Net income | ¥228 100 million (net income attributable to owners of the parent) |
| Results for the three months of the current quarter | Net Sales ¥538.0 billion / Operating profit ¥38.5 billion / Income before taxes ¥35.0 billion / Profit attributable to owners of the parent ¥22.8 billion |
| Full-year earnings forecast | Net Sales 22,000 Hundreds of millions of yen / Operating profit 1,500 Hundreds of millions of yen / Income before taxes 1,240 Hundreds of millions of yen / Profit attributable to owners of the parent 770 Hundreds of millions of yen / Dividend per share ¥210 / Operating profit margin 6.8 % / ROE 5.2 % |
| Progress against full-year forecast | Net Sales 24% / Operating profit 26% / By segment Architectural Glass 23%/23%, Automotive 27%/27%, Electronics 25%/27%, Chemicals 23%/27%, Life Science 22%/66%, Ceramics and Other 18%/38%, Total 24%/26% (revenue/operating profit for each segment) |
| Segment results | Segment Architectural Glass / Net Sales ¥112.0 billion (up ¥8.0 billion year on year) / Operating profit ¥4.7 billion (up ¥5.6 billion), Segment Automotive / Net Sales ¥137.6 billion (up ¥8.9 billion) / Operating profit ¥8.6 billion (up ¥1.0 billion), Segment Electronics / Net Sales ¥90.3 billion (up ¥3.6 billion) / Operating profit ¥12.3 billion (down ¥1.8 billion), Segment Chemicals / Net Sales ¥157.2 billion (up ¥13.1 billion) / Operating profit ¥15.2 billion (up ¥4.1 billion), Segment Life Science / Net Sales ¥35.6 billion (up ¥4.6 billion) / Operating profit -¥3.3 billion (up ¥2.8 billion), Segment Ceramics and Other / Net Sales ¥11.0 billion (down ¥2.4 billion) / Operating profit ¥0.8 billion (up ¥0.8 billion) |
| Breakdown of Factors Affecting the Change | Factors Foreign exchange impact / Amount +¥28.4 billion, Factors Impact of changes in the scope of consolidation / Amount -¥600 million, Factors Yen depreciation effect / Amount Amount not disclosed, Factors Higher shipments in Essential Chemicals Southeast Asia / Amount Amount not disclosed, Factors Effect of pricing measures in European Architectural Glass / Amount Amount not disclosed, Factors Improved profitability in Life Science / Amount Amount not disclosed, Factors Lower natural gas prices in Europe / Amount Amount not disclosed, Factors Increase in business structure improvement costs / Amount Amount not disclosed |
| Key KPIs | Indicator name D/E ratio / Value 0.41 times, Indicator name Full-year ROE forecast / Value 5.2 %, Indicator name Automobile production (Japan) / Value +2 % year on year, Indicator name Automobile production (North America) / Value ▲3, Indicator name Automobile production (Europe) / Value ▲3, Indicator name Display panel demand (global, area basis) / Value ▲1 |
| Unit price and quantity metrics | For architectural glass, automobile production and display panel demand, the materials provide volume and price or demand area data. Combinations such as customer numbers and average spending per customer are not disclosed. |
| Assumptions Underlying the Business Outlook | Item Average USD/JPY during the period / Value ¥155.0/USD, Item Average EUR/JPY during the period / Value ¥180.0/EUR, Item Crude oil (Dubai, average during the period) / Value 100.0 USD/BBL |
| Financial targets | ROE FY2026 forecast 5.2% / D/E ratio 0.37x at December 2025-end, 0.41x at March 2026-end / Equity ratio 50% at December 2025-end |
| Annual Dividend | Annual ¥210 per share / Interim and year-end Not disclosed |
| Capital expenditures | ¥441 100 million (FY2026 first quarter) / full-year forecast: ¥190.0 billion |
| New initiatives | Repair of architectural glass manufacturing furnaces, Expansion of electronics manufacturing equipment, including semiconductor-related equipment, Expansion of biopharmaceutical CDMO capacity, Diversification of procurement sources, cost reductions, production adjustments and appropriate pricing in response to the situation in the Middle East |
Items this document does not state (14)
Ordinary incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesSelf-assessment against the planNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue benefited from the weaker yen, higher shipments by Essential Chemicals in Southeast Asia and pricing measures in European Architectural Glass, while lower selling prices in that business and lower shipments in Architectural Glass in Europe and North America had a partial negative impact. In addition, operating profit benefited from improved profitability in Life Science and lower natural gas prices in Europe.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.